peptide elongation factor 2 has been researched along with nh 125 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bui, MH; Chen, Z; Donnelly, JB; Glaser, KB; Gopalakrishnan, SM; Johnson, EF; Soni, NB; Warrior, U | 1 |
| Ma, T; Ryazanov, AG; Yang, W; Zhou, X | 1 |
2 other study(ies) available for peptide elongation factor 2 and nh 125
| Article | Year |
|---|---|
1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; eIF-2 Kinase; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neoplasms; Peptide Elongation Factor 2; Phosphorylation; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases | 2011 |
Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Hippocampus; Imidazoles; Long-Term Potentiation; Mice, Transgenic; Neuronal Plasticity; Peptide Elongation Factor 2; Phosphorylation; Protein Biosynthesis; Receptor, Metabotropic Glutamate 5 | 2021 |